[White Paper] Cutting edge – Minimally Invasive Cardiovascular Surgery

Insights into the surgical products that are paving the way for new innovations in minimally invasive cardiovascular surgery

The challenge : Minimally Invasive vs. Open Surgery

The world of medicine evolves at a stunning pace. Procedures that were once cutting edge are now commonplace due to technological advances and procedural innovation. As a result of this scientific progress, minimally invasive surgeries are increasingly replacing open surgeries. But as with any medical procedure, patient outcomes are reliant on many factors, including access to the most beneficial surgical products for the corresponding procedure.

WHY PROVIDERS SHOULD CONSIDER NEW MINIMALLY INVASIVE TECHNIQUES

Typically, the largest incision for a minimally invasive CV surgical procedure is 6-7cm but can be as small as 4cm in some cases. These small incisions provide benefits to the patients such as:

• Pain reduction – Patients who undergo these procedures report far less pain and are less reliant on pain medication compared to those who have undergone conventional surgery.[1]
• Shorter hospital stay – A faster recovery means a shorter hospital stay. Example would be: Traditional open heart procedures require a minimum of a 7-10 day hospital stay and up to a 12 week absence from work, whereas an MIS CV procedure can result in 4-5 days in the hospital and the patient being back to work in 3-4 weeks.[2]
• Expedited recovery – Because the wounds are smaller, a patient can heal faster, rendering it possible to retain normalcy at a far quicker pace.[3]
• Less scarring – Smaller incisions result in fewer stitches, which typically means less prominent and noticeable scars.
• Increased precision – Smaller approaches create less trauma and decrease bleeding, lending to better visibility of the surgical field. This allows surgeons to better visualize certain cardiac structures and incision sites.

Products that make minimally invasive surgery more effective

Innovation is the cornerstone of progress in healthcare, and that’s especially true for the field of cardiovascular surgery. New products pave the way for that progress, offering better patient outcomes and new opportunities for practice expansion among providers.

CYGNET® Clamp

As a substitute for standard Steel Jawed Clamps, the CYGNET^® Clamp’s padded inserts cause less intimal damage. The CYGNET^® captures the best of both worlds for multiuse and aortic cross-clamping. The rigid shaft enables tunneling and accurate clamp placement and the flexible neck allows for improved surgeon visualization at the incision site.

Peters Surgical Sutures Corolene^®, Cardionyl^®, Cardioflon^® Evolution & Cardioxyl^®

Improved needle presentation and less suture strand memory leads to better surgeon handling. Optimal elasticity of thread allows for smooth passage through tissue and suture strength which ultimately ensures that once tied, it stays secure.

Peters Surgical — Advancing the World of Medicine

Innovation is part and parcel of science and medicine. Just because we discovered that minimally invasive surgery can be an effective substitute to open surgery does not mean that all progress stops there. Rather, we keep pressing onward.

At Peters Surgical, our mission is to improve a patient’s quality of care by contributing to the success of surgical procedures. We develop high-performance medical devices and dedicated services with and for surgical teams.

Sources

[1] NCBI. Comparison of the surgical outcomes of minimally invasive and open surgery for octogenarian and older compared to younger gastric cancer patients: a retrospective cohort study.
[2] NCBI. Minimally Invasive Abdominal Surgery.
[3] Yale Medicine. Minimally Invasive Surgery.